AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...
There wasn’t much Mac-related news at Apple’s latest to-do (to be expected at an iPhone event), aside from the announcement that macOS 26 would be available to the public on September 15. Historically ...